BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Doxycycline
,
rs3825942
,
IGF1
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
3-Methylglutaconic aciduria type 2
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
TAZ
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
Tafazzin
regulation of cardiolipin metabolic process
positive regulation of cardiolipin metabolic process
cardiolipin acyl-chain remodeling
Phospholipid/glycerol acyltransferase
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Cardiac gene expression in an inducible tafazzin shRNA knockdown mouse model of Barth syndrome
OMIM - Disorder of amino acid metabolism
OMIM - Congenital disorder
Explore Curated Studies Results
Literature
Most Relevant Literature
Barth syndrome.
Haematological features in Barth syndrome.
Barth syndrome diagnosed in the subclinical stage of heart failure based on the presence of lipid st…
Impaired cardiac reserve and severely diminished skeletal muscle O₂ utilization mediate exercise int…
Emergence and nature of mathematical difficulties in young children with Barth syndrome.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for 3-Methylglutaconic aciduria type 2
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ